Diaskintest is an innovative skin test for the mass screening of tuberculosis.

Diaskintest belongs to the IGRA tests, which are the most promising line in the diagnostics of infectious diseases. Diaskintest is highly specific, and does not show false-positive reactions in BCG-vaccinated persons. Diaskintest allows the identification of only a group of individuals with active tuberculosis infection or those at high risk of TB, minimizing the rate of false-positive results.

Since 2009, more than 20 million tests by Diaskintest have been made in the Russian Federation and CIS countries (Kazakhstan, Ukraine, Belarus, Kirgizstan, and Turkmenistan).

In 2014, Diaskintest earned an international award Prix Galien in biopharmaceutics.